Advisor Live: Optimizing Outcomes and Managing Costs - IV Acetaminophen and Liposomal Bupivacaine
Multimodal pain management is a treatment philosophy using multiple modalities to control post-operative pain with minimal side effects. Various agents (opioid vs. non-opioid), routes (oral, intravenous, neuraxial, regional) and modes (patient controlled vs. “as needed”) exist for the treatment of postoperative pain. An ever increasing level of evidence now supports a multimodal pain control approach with the intent to reduce opioid side effects (such as nausea and ileus) and improve pain scores/outcomes. Familiarity with the utilization and impacts of currently available pain control agents is a key step in developing treatment regimens that meet the needs of patients. Two newer treatment modalities in the post-operative pain space include liposomal bupivacaine and intravenous acetaminophen. This event will highlight Mercy Health’s experience with these agents and their use across the Mercy Health network. This webinar includes: Clinical utilization data for liposomal bupivacaine and intravenous acetaminophen (Performance Capsule report as an example) Mercy Health’s experience and processes related to multi-modal pain; specifically, liposomal buipivacaine and intravenous acetminophen Questions and answers with the panel EXPERT PRESENTERS Nathan Ash, Pharm D, MBA, BCPS, Director, Pharmacy Clinical Services, Mercy Health Rick Knudson, Pharm D, MS, MBA, BCPS, Senior Director, Pharmacy Member Support, Premier Inc. Ray Perigard, Director, Data Optimization, Premier Inc.